Top Markets
Coin of the day
Regenicin, Inc. Regenicin, Inc.

Regenicin, Inc.

RGIN
Rang in aandelen #41589
Regenicin, Inc. is dedicated to the development and commercialization of... Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$15.35K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Regenicin, Inc. (RGIN)

Categorie

Dividendrendementgeschiedenis voor Regenicin, Inc. (RGIN)
Het dividendrendement (TTM) van Regenicin, Inc. (aandelsymbool: RGIN) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Regenicin, Inc. (RGIN) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten